Theiler's murine encephalomyelitis virus (TMEV)
infection produces a chronic inflammatory disease of the spinal cord white matter, with striking similarities to both
experimental allergic encephalomyelitis (EAE) and human
multiple sclerosis (MS). The first phase of
demyelination in this model appears to be dependent on a delayed-type
hypersensitivity (DTH) response to
viral antigens, driven by CD4+, Th1 lymphocytes. Macrophages, recruited in the infected CNS, would be responsible for most of the myelin damage. Recently, new populations of CD4+ lymphocytes were demonstrated in infected mice, this time with specificity for myelin
antigens, particularly PLP. This suggests that, in the chronic phase of the disease, an autoimmune mechanism of
demyelination, similar to EAE, may participate in the process of myelin destruction. The present study represents a first step in exploring the functional activity of these anti-myelin lymphocytes that emerge during the chronic phase of the disease. Lymphocytes were removed from chronically infected animals, they were stimulated with the major PLP encephalitogenic
epitope for SJL/J mice, and they were added to organotypic myelinated spinal cord cultures for different lengths of time. Results show that lymphocytes stimulated with the major PLP
epitope have a powerful capacity for demyelinating these cultures, while MBP stimulated lymphocytes and lymphocytes from control animals do not. This study, suggests that the anti-myelin response that emerges during the chronic phase of the
infection is functionally active. A similar phenomenon of
epitope spreading from virus to organ specific
antigens may take place in humans and be involved in a number of immune-mediated diseases, including MS.